レジメン名 | レジメンNo |
---|---|
3wTrastuzumab | 05010 |
3wTrastuzumab+wPAC | 05033 |
Atezolizumab+nabPAC | 05035 |
ddEC→ddPAC | 05032 |
DOC | 05004 |
DOC+Trastuzumab(進行・再発) | 05027 |
DOC+Trastuzumab→Trastuzumab(周術期) | 05030 |
EC | 05002 |
Eriburin | 05018 |
GEM | 05015 |
Pertuzumab+Trastuzumab | 05023 |
Pertuzumab+Trastuzumab+DOC | 05025 |
Pertuzumab+Trastuzumab+wPAC | 05022 |
Pembrolizumab | 99001 |
TC | 05011 |
Trastuzumab Emtansine | 05028 |
VNR | 05005 |
wTrastuzumab | 05007 |
wPAC | 05003 |
Pembrolizumab+GEM+CBDCA | 05039 |
Pembrolizumab+PAC | 05040 |
Pembrolizumab+nabPAC | 05041 |
Pembrolizumab+[CBDCA+PAC→EC] | 05042 |
Trastuzumab Deruxtecan | 05037 |
ADM+IFM | 05043 |
Pembrolizumab(6週毎) | 99002 |
医療関係者の方